Journal for ImmunoTherapy of Cancer (JITC)
Journal Descriptions
The Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer-reviewed journal that aims to enrich communication and advance scientific understanding in the rapidly evolving fields of tumor immunology and cancer immunotherapy. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity. The Journal for ImmunoTherapy of Cancer is an open access journal that publishes high quality research, literature reviews, position papers and practice guidelines, and case studies on all components of cancer immunology and immunotherapy. The Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer-reviewed journal that aims to enrich communication and advance scientific understanding in the rapidly evolving fields of tumor immunology and cancer immunotherapy. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
Journal for ImmunoTherapy of Cancer (JITC) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Toxicology, Pharmaceutics, Immunology, Allergy, Oncology, Microbiology , Online , Continuously Journal
- UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2051-1426, Established: 2024, Impact Factor: 10.9
- Provides Crossref DOI
-
Indexed in: Scopus, WoS, DOAJ, PubMed
-
Not indexed in UGC CARE
